1-1 of 1
Yannick LE Bris, MD PharmD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Poor Prognosis Associated with Gains of CCND1 in Mantle Cell Lymphoma Treated By First Line Immuno-Chemotherapy — a Study By the Lysa Group

Yannick LE Bris, MD PharmD, Olivier Theisen, MD, Anne Moreau, MD, Florence Magrangeas, PhD, Danielle Canioni, MD, Barbara Burroni, MD, Catherine Thieblemont, MD, Lucie Oberic, MD, Krimo Bouabdallah, MD, Emmanuel Gyan, MD PhD, David Chiron, PhD, Catherine Pellat-deceunynck, PhD, Benoit Tessoulin, MD, Catherine Godon, MD, Marie-Helene Delfau, MD, Mary Callanan, PhD, Stephane Minvielle, PhD, Marie C Bene, PharmSci, PhD, Olivier Hermine, MD PhD, Steven LE Gouill, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4099.
https://doi.org/10.1182/blood-2018-99-113303
Published: 2018